Product Categories
| Country: | China |
|---|---|
| Tel: | 86-2558409506 |
| Mobile: | 18913920737 |
| E-mail: | louis@lidepharma.com |
| QQ: | 834303752 |
| Skype: | Chat Now! |
| Address: | 24F, 5#, No.6 Pukou Avenue, |
|
LIDE PHARMACEUTICALS LTD.was established in Apr.,2010 located Nanjing. We are a company that provides customized development and production services (CDMO) for global chemical and pharmaceutical companies and scientific research institutions. We are mainly committed to providing process development, pilot, and commercial production of key intermediates and Active Pharmaceutical Ingredients for innovative drugs and generic drugs, and a one-stop solution service provider for designing, synthesizing and the document registration of drug molecular building blocks in the international market. In 2018, a customized research and development (CRO) center was set up in Wujiang, Suzhou with available analysis and test, as the leading compound screening test and project evaluation frontier. In 2019 our factory was built in Beigou Chemical Park, Penglai, Shandong Province with four production and synthesized workshops, equipped with special reaction equipment such as ultra-low temperature, high pressure, ultra high temperature, and high vacuum. So far we have finished the closed loop of the upstream industry from research to enlarge production. The sales network is distributed in Nanjing, Shanghai and Hong Kong and a professional and thoughtful business team has been formed to serve foreign customers are widespread in 60 countries in the world. We always adhere to the highest principle of customer value realization, uphold altruistic thinking and self-service consciousness as the criterion, customer-centric, customer demand-oriented, continuous innovation, rapid response, providing projects from confirmation, progress tracking, active feedback, sample testing and value-added services. We take the delivery that meet customer quality standards and the required supporting docs. Since the establishment of the company, we have maintained a good reputation of zero complaints after sales. We are determined to become a century-old enterprise and help customers succeed in their area.
|
|
| Product Name | MF | CAS | Details |
|---|
| 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene | C39H32OP2 | 161265-03-8 | Details |
| Sitagliptin | C16H15F6N5O | 486460-32-6 | Details |
| Calcitriol | C27H44O3 | 32222-06-3 | Details |
| 3',5'-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE | C8H3Cl2F3O | 130336-16-2 | Details |
| Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| Alectinib Hydrochloride | C30H35ClN4O2 | 1256589-74-8 | Details |
| 3-Chloropropyl isocyanate | C4H6ClNO | 13010-19-0 | Details |
| 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide | C12H17N3O5S | 1228779-96-1 | Details |
| 3-Methylenedihydro-2(3H)-furanone | C5H6O2 | 547-65-9 | Details |
| Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate | C15H11FN2O3 | 1235865-75-4 | Details |
| 8-Aminooctanoic acid | C8H17NO2 | 1002-57-9 | Details |
| Ropivacaine hydrochloride | C17H26N2O.ClH.H2O | 132112-35-7 | Details |
| (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol | C27H46N2O3 | 119302-20-4 | Details |
| Bis(methylthio)methane | C3H8S2 | 1618-26-4 | Details |
| Mupirocin | C26H44O9 | 12650-69-0 | Details |
| Sitagliptin phosphate monohydrate | C16H20F6N5O6P | 654671-77-9 | Details |
| Tranexamic Acid | C8H15NO2 | 1197-18-8 | Details |
| Diethyl(3-pyridyl)borane | C9H14BN | 89878-14-8 | Details |
| N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide | C14H23N3O2 | 356068-86-5 | Details |
| Apremilast | C22H24N2O7S | 608141-41-9 | Details |
| RAD 140 | C20H16ClN5O2 | 1182367-47-0 | Details |
| Dulaglutide | 923950-08-7 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride | C19H28Cl2N2 | 1628047-87-9 | Details |
| Vigabatrin | C6H11NO2 | 60643-86-9 | Details |
| Pyrazinecarbonitrile | C5H3N3 | 19847-12-2 | Details |
| 2-Amino-5-chlorobenzophenone | C13H10ClNO | 719-59-5 | Details |
| (R)-2-(1-aminoethyl)-4-fluorophenol hydrochloride | C8H11ClFNO | 1802222-53-2 | Details |
| Bupivacaine hydrochloride | C18H28N2O.ClH | 14252-80-3 | Details |
| Calcipotriene | C27H40O3 | 112828-00-9 | Details |
| Diethyl cyanophosphonate | C5H10NO3P | 2942-58-7 | Details |
| Indomethacin | C19H16ClNO4 | 53-86-1 | Details |
| (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | C17H23NO5 | 143527-70-2 | Details |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
| Sunitinib malate | C26H33FN4O7 | 341031-54-7 | Details |
| 2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid | C12H15IO2 | 1256584-73-2 | Details |
| (R)-(+)-2-Methyl-2-propanesulfinamide | C4H11NOS | 196929-78-9 | Details |
| Liraglutide | C172H265N43O51 | 204656-20-2 | Details |
| Gadolinium DOTA meglumine | C23H42GdN5O13 | 92943-93-6 | Details |
| GW501516 | C21H18F3NO3S2 | 317318-70-0 | Details |
| Isavuconazole | C22H17F2N5OS | 241479-67-4 | Details |
| Eribulin Mesylate | C41H63NO14S | 441045-17-6 | Details |
| Tucatinib | C26H24N8O2 | 937263-43-9 | Details |
| Zolmitriptan | C16H21N3O2 | 139264-17-8 | Details |
| Aprotinin | C284H432N84O78R2S7 | 9087-70-1 | Details |
| 5-Fluoro-2-oxindole | C8H6FNO | 56341-41-4 | Details |
| 10-Deacetylbaccatin III | C29H36O10 | 32981-86-5 | Details |
| LOXO-292 | C29H31N7O3 | 2152628-33-4 | Details |
| Docetaxel trihydrate | C43H55NO15 | 148408-66-6 | Details |
| Docetaxel intermediate | C49H55Cl6NO18 | 114915-14-9 | Details |
| Ibutamoren Mesylate; MK-677; MK 677 | C28H40N4O8S2 | 159752-10-0 | Details |
| YK-11 | C25H34O6 | 431579-34-9 | Details |
| Ectoine | C6H10N2O2 | 96702-03-3 | Details |
| L-Prolinamide | C5H10N2O | 7531-52-4 | Details |
| Amantadine HCl | C10H18ClN | 665-66-7 | Details |
| 4,4,5, 5-tetramethyl-2-[(2E)-3-(trimethylsilyI) -2-propen- 1-yI]-1,3,2-Dioxaborolane | C12H25BO2Si | 79309-68-5 | Details |
| Caspofungin acetate; Cancidas | C54H92N10O17 | 179463-17-3 | Details |
| Rucaparib | C19H18FN3O | 283173-50-2 | Details |
| Cyclen | C8H20N4 | 294-90-6 | Details |
| Acotiamide hydrochloride trihydrate | C21H31ClN4O5S | 773092-05-0 | Details |
| Ponatinib Hydrochloride | C29H28ClF3N6O | 1114544-31-8 | Details |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | C15H19N3O2 | 1267610-26-3 | Details |
| Sarolaner | C23H18Cl2F4N2O5S | 1398609-39-6 | Details |
| Tris(2-methyl-1-aziridinyl)phosphine oxide | C9H18N3OP | 57-39-6 | Details |
| Exemestane | C20H24O2 | 107868-30-4 | Details |
| 3-Amino-1-hydroxyadamantane | C10H17NO | 702-82-9 | Details |
| N-Methyl-4-chloropyridine-2-carboxamide | C7H7ClN2O | 220000-87-3 | Details |
| Lysergol | C16H18N2O | 602-85-7 | Details |
| Alectinib | C30H34N4O2 | 1256580-46-7 | Details |
| Venetoclax | C45H50ClN7O7S | 1257044-40-8 | Details |
| Cytarabine | C9H13N3O5 | 147-94-4 | Details |
| Thiazole-4-carboxaldehyde | C4H3NOS | 3364-80-5 | Details |
| Methyl L-phenylalaninate hydrochloride | C10H14ClNO2 | 7524-50-7 | Details |
| Tert-butyl bis(2-chloroethyl)carbamate | C9H17Cl2NO2 | 118753-70-1 | Details |
| Sitagliptin phosphate | C16H15F6N5O.H3PO4 | 654671-78-0 | Details |
| Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| 4-Chloro-2-butanone | C4H7ClO | 6322-49-2 | Details |
| Vinblastine sulfate | C46H60N4O13S | 143-67-9 | Details |
| Thiophene-3,4-dicarboxylic acid | C6H4O4S | 4282-29-5 | Details |
| Deferasirox | C21H15N3O4 | 201530-41-8 | Details |
| 2,3-Dichlorobenzoyl cyanide | C8H3Cl2NO | 77668-42-9 | Details |
| Vanillyl butyl ether | C12H18O3 | 82654-98-6 | Details |
| Isoquinolin-6-ol | C9H7NO | 7651-82-3 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine | C19H27ClN2 | 1228780-72-0 | Details |
| 2-Hydroxy-5-nitropyridine | C5H4N2O3 | 5418-51-9 | Details |
| Allicin | C6H10OS2 | 539-86-6 | Details |
| Calcipotriol Monohydrate | C27H42O4 | 147657-22-5 | Details |
| 2-Benzoylpyrrole | C11H9NO | 7697-46-3 | Details |
| (4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid | C22H25NO6 | 196404-55-4 | Details |
| Nitrofurantoin monohydrate | C8H8N4O6 | 17140-81-7 | Details |
| Droperidol | C22H22FN3O2 | 548-73-2 | Details |
| (-)-Huperzine A | C15H18N2O | 102518-79-6 | Details |
| Sorafenib Tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| LGD 4033 | C14H12F6N2O | 1165910-22-4 | Details |
| Delafloxacin meglumine | C25H29ClF3N5O9 | 352458-37-8 | Details |
| 2-Phenylpropionic acid | C9H10O2 | 492-37-5 | Details |
| Vincristine Sulfate | C46H58N4O14S | 2068-78-2 | Details |
| Everolimus | C53H83NO14 | 159351-69-6 | Details |
| 1'-Acetonaphthone | C12H10O | 941-98-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||